Skip to main content

Find Clinical Trials

Home
Conditions
Neoplastic Processes

Clinical trial condition

Neoplastic Processes

Explore clinical trials studying Neoplastic Processes. Study availability and eligibility vary by location and protocol.

3,270 public trials 686 recruiting studies

Refine in advanced search Browse all conditions

Neoplastic Processes trial results

Completed

Anti-PD-1 Monoclonal Antibody in Advanced, Trastuzumab-resistant, HER2-positive Breast Cancer

NCT02129556

Conditions: Breast Diseases, Breast Neoplasms, Metastatic Breast Cancer, +8 more
Locations: Peter MacCallum Cancer Centre East Melbourne, Australia

Westmead Hospital Westmead, Australia

Medical University of Vienna Vienna, Austria

Jules Bordet Institute Brussels, Belgium

View Trial Details

Completed

Stereotactic Radiosurgery for Patients With Hepatic Metastases.

NCT00547677

Conditions: Metastatic Cancer, Neoplasm Metastasis, Neoplasms, +4 more
Locations: University of Minnesota Cancer Center Minneapolis, Minnesota, United States

Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas Dallas, Texas, United States

View Trial Details

Completed

A Phase II Study of Bevacizumab, Irinotecan and Capecitabine in Patients With Previously Untreated Metastatic Colorectal Cancer

NCT00483834

Conditions: Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +13 more
Locations: Princess Margaret Hospital Toronto, Ontario, Canada

View Trial Details

Completed

Once-daily Oral Seviteronel in Patients With Castration-Resistant Prostate Cancer Progressing on Enzalutamide or Abiraterone.

NCT02445976

Conditions: Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +12 more
Locations: University of Alabama Birmingham, Alabama, United States

Mayo Clinic Scottsdale, Arizona, United States

University of California at Los Angeles Los Angeles, California, United States

Yale University New Haven, Connecticut, United States

View all 21 locations

View Trial Details

Completed

Changes in Biomarkers From Blood Over Time in Patients With Pancreatic Adenocarcinoma

NCT02974764

Conditions: Biological Markers, Digestive System Diseases, Digestive System Neoplasms, +12 more
Locations: Johns Hopkins University Baltimore, Maryland, United States

View Trial Details

Completed

BKM120 For Triple Negative Breast Cancer

NCT01790932

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +8 more
Locations: Dana-Farber Cancer Institute at Faulkner Hospital Boston, Massachusetts, United States

Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

Brigham and Women's Hospital Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

A Study of Sunitinib in Patients With Metastatic or Recurrent Thymic Carcinoma

NCT02623127

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Lymphatic Diseases, +13 more
Locations: Seoul National University Bundang Hospital Seongnam, South Korea

View Trial Details

Completed

Donor Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies

NCT01093586

Conditions: Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Megakaryoblastic Leukemia (M7), +141 more
Locations: Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

NGR-hTNF in Combination With an Anthracycline in Platinum-resistant Ovarian Cancer (NGR018)

NCT03804866

Conditions: Adnexal Diseases, Disease Attributes, Disease Progression, +19 more
Locations: Ospedale San Raffaele Milan, Italy

Fondazione IRCCS Istituto Nazionale dei Tumori Milan, Italy

Istituto Europeo di Oncologia Milan, Italy

Istituto Nazionale Tumori IRCCS Fondazione "Giovanni Pascale" Naples, Italy

View Trial Details

Completed

Evaluation of the Predictive and Prognostic Value of Germ-line Polymorphisms in Patients With Metastatic Breast Cancer

NCT01460186

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +9 more
Locations: Hôpital Jean Minjoz - CHU Besançon Besançon, France

Institut Bergonié Bordeaux, France

Centre François Baclesse Caen, France

Centre Georges François Leclerc Dijon, France

View all 17 locations

View Trial Details